Against BC via PI3K-AKT-PTGS2 and EGFR-reticular activating system- Recombinant C-Raf Proto Oncogene Serine - mitogen-activated protein- extracellular regulated protein kinases (RAS-RAF-MEK-ERK) pathways. This evidence concerns the gene MAPK1 and breast cancer.